Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anton Hübner is a long-established German healthcare company specializing in the development and manufacture of natural remedies, dietary supplements, and natural cosmetics. Founded in 1936 and headquartered in Ehrenkirchen, the company is best known for its Silicea line, which utilizes colloidal silica for skin, hair, and nail health. Its portfolio also includes the Tannenblut brand for respiratory support and various products for joint and gastrointestinal health. Since 2011, Anton Hübner has operated as a subsidiary of the Dermapharm Group, leveraging its expertise in traditional herbal medicine and modern natural health solutions. The company maintains a strong presence in the European pharmacy and health food store markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anton Hübner.